- Experts Gather to Share Experience and Discuss Best Practices in Shrimp Disease Management -
JAKARTA, Indonesia, Nov. 22, 2013 (ANTARA/PRNewswire) -- Life Technologies Corporation today announced that the Ministry of Marine Affairs and Fisheries of Indonesia and Life Technologies convened a first joint symposium on Southeast Asia Shrimp Disease on the 21st of November in Jakarta.
Southeast Asia is the largest shrimp exporting region in the world. In Indonesia, shrimp exports account for more than 35% of total fishery exports for the country. The Southeast Asia region is not only facing the increasing demands of the globalized food market but also the challenge of diseases spreading through shrimp farms in the region. Management of shrimp diseases including pathogen identification and protection has become a key challenge, not just to the shrimp farming industry but also to the governments who supports the industry in their countries.
The symposium brought together experts in the shrimp industry and focused on sharing their experience and good practices to meet these challenges, including discussions on the economic significance of disease management, scientific knowledge including the beneficial aspects of adopting high-throughput protocols to identify shrimp pathogens and utilizing the most advanced genetic analysis technologies for infectious shrimp disease discovery and surveillance.
More than 150 delegates from the government, aquaculture business and academic sectors in countries including Indonesia, Vietnam, Philippines, Thailand, Singapore and Australia gathered to share their views and exchange opinions with their peers.
Contributing speakers were, Dr. Matthew Briggs (Ridley AgriProducts, Brisbane, Australia), Dr. Siripong Thitamadee (Centex Shrimp, Thailand), Dr. Yuri Sutanto (PT Central Proteina Prima Indonesia), Dr. Leobert dela Pena (Aquaculture Department, SEAFDEC, Philippines), Ms. Dao Thi Thanh Hue (Regional Animal Health Office No.6, Vietnam), Dr. Kim Halpin and Dr. Kristian Ridley from Life Technologies.
"The Ministry is committed to progress the aquaculture industry of Indonesia and we are very happy that this collaboration between industry, institutions and the administration could happen." said Mr. Maskur, Director of Fish Health and Environment, Directorate General of Aquaculture, Ministry of Marine Affairs and Fisheries, Indonesia, at the symposium opening. "This is an important step forward for the shrimp industry, to exchange knowledge and best practices to overcome the challenges that we face."
"We are delighted that we could hold this joint symposium as a company that has the technology and knowledge of needed support to the aqua farming industry." said Justin Lee, Regional Head of Southeast Asia at Life Technologies."We look forward to contributing with our expertise to the industry as a partner of finding solutions for better aquaculture."
Life Technologies' animal health business works to deliver standardized protocols and assays to detect the pathogens of the shrimp diseases listed in The World Organization for Animal Health (OIE).
Life Technologies Animal Health products are for veterinary use only and for in vitro use only. Regulatory requirements vary by country; products may not be available in your geographic area.
About Life Technologies
Life Technologies Corporation (NASDAQ: LIFE) is a global biotechnology company that is committed to providing the most innovative products and services to leading customers in the fields of scientific research, genetic analysis and applied sciences. With a presence in more than 180 countries, the company's portfolio of 50,000 end-to-end solutions is secured by more than 5,000 patents and licenses that span the entire biological spectrumâ€”scientific exploration, molecular diagnostics, 21st century forensics, regenerative medicine and agricultural research. Life Technologies has approximately 10,000 employees and had sales of $3.8 billion in 2012.
Life Technologies' Safe Harbor Statement
This press release includes forward-looking statements about our anticipated results that involve risks and uncertainties. Some of the information contained in this press release, including, but not limited to, statements as to industry trends and Life Technologies' plans, objectives, expectations and strategy for its business, contains forward-looking statements that are subject to risks and uncertainties that could cause actual results or events to differ materially from those expressed or implied by such forward-looking statements. Any statements that are not statements of historical fact are forward-looking statements. When used, the words "believe," "plan," "intend," "anticipate," "target," "estimate," "expect" and the like, and/or future tense or conditional constructions ("will," "may," "could," "should," etc.), or similar expressions, identify certain of these forward-looking statements. Important factors which could cause actual results to differ materially from those in the forward-looking statements are detailed in filings made by Life Technologies with the Securities and Exchange Commission. Life Technologies undertakes no obligation to update or revise any such forward-looking statements to reflect subsequent events or circumstances.
Life Technologies Media Contact: